Month: July 2025
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) — Ponce Financial Group, Inc., (the “Company”) (NASDAQ: PDLB), the holding company for Ponce Bank (the “Bank”), today announced results for the second quarter of 2025.
Second Quarter 2025 Highlights (Compared to Prior Periods):Net income available to common stockholders was $5.8 million, or $0.25 per diluted share for the three months ended June 30, 2025, as compared to net income available to common stockholders of $5.7 million, or $0.25 per diluted share for the three months ended March 31, 2025, and net income available to common stockholders of $3.1 million, or $0.14 per diluted share for the three months ended June 30, 2024. Total net income for the three months ended June 30, 2025, was $6.1 million. The Company paid dividends of $0.3 million on its preferred stock during the three...
Postal Realty Trust, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
Written by Customer Service on . Posted in Public Companies.
CEDARHURST, N.Y., July 25, 2025 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,150 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, announced today that it will report its financial results for the period ended June 30, 2025, on Monday, August 4, 2025, after market close.
Webcast and Call Information:
The Company will host a webcast and conference call to discuss the second quarter 2025 financial results on Tuesday, August 5, 2025, at 9:00 A.M. Eastern Time. A live audio webcast of the conference call will be available on the Company’s investor website at https://investor.postalrealtytrust.com/Investors/events-and-presentations/default.aspx....
Colliers completes acquisition of Astris Finance
Written by Customer Service on . Posted in Public Companies.
TORONTO and WASHINGTON, D.C., July 25, 2025 (GLOBE NEWSWIRE) — Global diversified professional services and investment management company, Colliers (NASDAQ, TSX: CIGI), announced today it has completed its previously announced acquisition of a controlling interest in Astris Infrastructure, LLC (“Astris Finance”), a global investment banking firm specializing in infrastructure and energy transition. The acquisition significantly expands Colliers’ investment banking capabilities and capitalizes on the growing global demand for infrastructure that supports urbanization, energy security, and decarbonization.
Colliers Contact
Christian MayerChief Financial Officer+1 416 960 9500
About Colliers
Colliers (NASDAQ, TSX: CIGI) is a global diversified professional services and investment management company. Operating through three industry-leading...
Pampa Metals and Rugby Resources Complete Arrangement Transaction
Written by Customer Service on . Posted in Public Companies.
(CSE: PM) (FSE: FIR) (OTCQB: PMMCF) For Immediate Release
Vancouver, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) — Pampa Metals Corporation (“Pampa Metals”) (CSE:PM / FSE:FIR / OTCQB:PMMCF) and Rugby Resources Ltd. (“Rugby”) (TSXV:RUG) are pleased to announce completion of the acquisition of all the issued and outstanding common shares of Rugby (the “Rugby Shares”) by Pampa Metals (refer April 22, 2025 News Release). Under the terms of the court approved arrangement (the “Arrangement”), 65,165,185 common shares of Pampa Metals (the “Pampa Shares”) are being issued in connection with closing to former Rugby shareholders on the basis of one Pampa Share for every 6.4 Rugby Shares.
In connection with the Arrangement, Bryce Roxburgh, outgoing President and CEO, of Rugby has been appointed to the board of directors of Pampa...
BriaCell Announces Two Clinical Data Poster Presentations at ESMO 2025
Written by Customer Service on . Posted in Public Companies.
PHILADELPHIA and VANCOUVER, British Columbia, July 25, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces two clinical data poster presentations at the European Society for Medical Oncology (ESMO) Congress 2025 Annual Meeting taking place October 17 – 21 in Berlin, Germany.
The titles of the poster presentations are listed below.
#8212: Phase III Pivotal Trial of Bria-IMT + CPI vs Physician’s Choice in Advanced Metastatic Breast Cancer (BRIA-ABC)
#3928: Feasibility and Biomarker Validation of an International Randomized Phase 3 Trial of Bria-IMT Cell Therapy in Late Stage MBC (BRIA-ABC)
Abstracts will be published online via the ESMO website at 00:05...
Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo
Written by Customer Service on . Posted in Public Companies.
NEW YORK and MELBOURNE, Australia, July 25, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces the appointment of Charlene E. Gamaldo, M.D. to its IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board.
Incannex Chief Medical Officer Dr. Lou Barbato commented:“We are fortunate to welcome Dr. Gamaldo to the Incannex Clinical Advisory Board. Her leadership across neurology, psychiatry, and public health, combined with a distinguished track record in sleep medicine, brings tremendous value to our obstructive sleep apnea program. With the highly anticipated Phase 2 data readout for IHL-42X expected next week, Dr. Gamaldo’s appointment reflects our growing confidence...
Bombardier Delivers the First Challenger 3500 Business Jet in Costa Rica
Written by Customer Service on . Posted in Public Companies.
The delivery underscores the growing presence and global success of Bombardier in Central America
The Challenger 3500 is ideally suited for the Central American market, offering the perfect balance of range, efficiency, and versatility to connect key regional citiesMONTRÉAL, July 25, 2025 (GLOBE NEWSWIRE) — Bombardier today announced the delivery of its first Challenger 3500 business jet in Costa Rica, marking a significant milestone for the company in Central America. With a platform that has consistently led the super-midsize segment for over two decades, the Challenger 3500 aircraft offers the ultimate combination of performance, comfort and reliability to customers around the world.
“With its high reliability, modern cabin and exceptional runway performance, the Challenger 3500 has quickly established itself as the aircraft...
Form 8.3 – [MARLOWE PLC – 24 07 2025] – (CGWL)
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION(a) Full name of discloser:
CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree
MARLOWE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
N/A(e) Date position held/dealing...
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
Written by Customer Service on . Posted in Public Companies.
CAMBRIDGE, Mass., July 25, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending marketing authorization for ZURZUVAE® (zuranolone) for the treatment of postpartum depression (PPD) in adults following childbirth. If approved by the European Commission (EC), ZURZUVAE will be the first treatment authorized within the European Union specifically indicated to treat depressive symptoms for women with PPD. ZURZUVAE is a once-daily, oral, 14-day treatment which was approved by the U.S. Food and Drug Administration (FDA) in 2023.
“This is an important milestone for maternal health in the European Union,” said Priya Singhal, M.D., M.P.H., Head of Development at Biogen. “ZURZUVAE represents a novel...
Valeura Energy Inc.: Strategic Farm-in Agreement with PTTEP
Written by Customer Service on . Posted in Public Companies.
Major Offshore Acreage Expansion Creates New Growth Platform in the Gulf of ThailandSINGAPORE, July 25, 2025 (GLOBE NEWSWIRE) — Valeura Energy Inc. (TSX:VLE, OTCQX:VLERF) (“Valeura” or the “Company”) is pleased to announce that it has entered into a Farm-in Agreement with PTT Exploration and Production Plc (“PTTEP”), through its subsidiary, PTTEP Energy Development Company Limited to earn a 40% interest in Blocks G1/65 and G3/65 (the “Blocks”), in the offshore Gulf of Thailand (the “Farm-in”).
Key HighlightsStrategic Partnership: Farm-in Agreement with PTTEP, the largest oil and gas explorer, producer, and operator in Thailand;
Substantial Acreage Expansion: Increases Valeura’s gross acreage position in Thailand from 2,623 km² to 22,757 km²;
Prime Location Adjacent...